Establishment Labs (ESTA) Competitors $29.97 +0.18 (+0.60%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$30.00 +0.03 (+0.10%) As of 04/25/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. SLNO, IRTC, TMDX, PRCT, NVST, LMAT, LIVN, ENOV, NVCR, and CNMDShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Enovis NovoCure CONMED Establishment Labs (NASDAQ:ESTA) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership. Do analysts rate ESTA or SLNO? Establishment Labs presently has a consensus target price of $57.40, suggesting a potential upside of 91.52%. Soleno Therapeutics has a consensus target price of $104.67, suggesting a potential upside of 42.87%. Given Establishment Labs' higher probable upside, equities analysts clearly believe Establishment Labs is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20 Does the MarketBeat Community prefer ESTA or SLNO? Soleno Therapeutics received 202 more outperform votes than Establishment Labs when rated by MarketBeat users. Likewise, 72.62% of users gave Soleno Therapeutics an outperform vote while only 61.98% of users gave Establishment Labs an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11961.98% Underperform Votes7338.02% Soleno TherapeuticsOutperform Votes32172.62% Underperform Votes12127.38% Does the media prefer ESTA or SLNO? In the previous week, Soleno Therapeutics had 5 more articles in the media than Establishment Labs. MarketBeat recorded 12 mentions for Soleno Therapeutics and 7 mentions for Establishment Labs. Soleno Therapeutics' average media sentiment score of 1.36 beat Establishment Labs' score of 0.94 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ESTA or SLNO? Establishment Labs has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.29, meaning that its stock price is 329% less volatile than the S&P 500. Is ESTA or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Establishment Labs' net margin of -46.13%. Soleno Therapeutics' return on equity of -61.99% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Soleno Therapeutics N/A -61.99%-55.21% Do insiders & institutionals believe in ESTA or SLNO? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 12.3% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has preferable valuation and earnings, ESTA or SLNO? Soleno Therapeutics has lower revenue, but higher earnings than Establishment Labs. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.03M5.21-$78.50M-$2.98-10.06Soleno TherapeuticsN/AN/A-$38.99M-$4.26-17.20 SummarySoleno Therapeutics beats Establishment Labs on 12 of the 18 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$864.52M$9.08B$5.46B$7.81BDividend YieldN/A1.67%5.43%4.26%P/E Ratio-11.6219.3322.4318.46Price / Sales5.2173.96391.42101.46Price / CashN/A19.6738.1834.62Price / Book42.214.916.684.19Net Income-$78.50M$284.66M$3.22B$248.05M7 Day Performance-4.71%7.21%6.25%6.54%1 Month Performance-26.25%-1.01%-2.70%-1.97%1 Year Performance-38.17%-16.86%16.86%4.72% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.5369 of 5 stars$29.97+0.6%$57.40+91.5%-38.2%$864.52M$166.03M-11.62960Gap UpSLNOSoleno Therapeutics4.6452 of 5 stars$68.93-1.5%$99.63+44.5%+93.3%$3.16BN/A-20.7630Analyst ForecastPositive NewsIRTCiRhythm Technologies1.0143 of 5 stars$98.63-2.3%$119.73+21.4%-5.3%$3.10B$591.84M-27.101,790Upcoming EarningsNews CoveragePositive NewsTMDXTransMedics Group2.9947 of 5 stars$87.72-0.6%$122.70+39.9%+1.5%$2.97B$441.54M93.32210Upcoming EarningsAnalyst ForecastPRCTPROCEPT BioRobotics2.7122 of 5 stars$53.43+0.8%$91.43+71.1%+1.3%$2.93B$224.50M-27.40430Earnings ReportAnalyst ForecastNews CoveragePositive NewsHigh Trading VolumeNVSTEnvista4.5216 of 5 stars$14.88-2.0%$19.96+34.2%-21.7%$2.56B$2.51B-2.2912,700Upcoming EarningsNews CoverageLMATLeMaitre Vascular2.3048 of 5 stars$84.72-1.8%$95.25+12.4%+39.9%$1.91B$219.86M46.30490Upcoming EarningsNews CoveragePositive NewsLIVNLivaNova3.6902 of 5 stars$34.61-2.7%$61.17+76.7%-32.9%$1.88B$1.25B82.402,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.7257 of 5 stars$32.25+0.9%$58.50+81.4%-36.6%$1.84B$2.11B-14.736,800News CoveragePositive NewsNVCRNovoCure3.7053 of 5 stars$15.58flat$34.17+119.3%+46.4%$1.71B$605.22M-11.131,320Earnings ReportAnalyst ForecastNews CoverageCNMDCONMED4.6501 of 5 stars$47.71-1.8%$77.20+61.8%-23.0%$1.48B$1.31B11.254,100Upcoming EarningsNews Coverage Related Companies and Tools Related Companies Soleno Therapeutics Alternatives iRhythm Technologies Alternatives TransMedics Group Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives LeMaitre Vascular Alternatives LivaNova Alternatives Enovis Alternatives NovoCure Alternatives CONMED Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ESTA Stock Free ESTA Stock Alerts